Biolife Solutions Inc
BLFS
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
103.5% downsideOvervalued by 103.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.22 Billion |
|---|---|
| Enterprise Value | $1.21 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.25 |
| Beta | 1.97 |
| Outstanding Shares | 48,458,536 |
Return
| Return on Equity | -2.82% |
|---|---|
| Return on Assets | -2.62% |
| Return on Invested Capital | -3.41% |
Valuation & Multiples
| P/E Ratio | -115.05 |
|---|---|
| PEG | 31.54 |
| Price to Sales | 13.63 |
| Price to Book Ratio | 3.89 |
| Enterprise Value to Revenue | 12.14 |
| Enterprise Value to EBIT | -92.79 |
| Enterprise Value to Net Income | -116 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 104.43%▲ 2.33% |
|---|---|
| Total Invested | $951.26M▼ 19.61% |
| Investors Holding | 186▲ 1.00% |
ESG Score
No data
About Biolife Solutions Inc
CEO: Michael Rice Relevant Senate Committees
This powerful committee's control over taxation, trade policy, and entitlement spending (like Medicare pricing for medical devices) directly impacts BLFS's profitability, market access, and revenue streams, making it highly relevant.
The Appropriations Committee directly allocates federal spending to agencies and programs (e.g., NIH, VA, federal hospitals) that are significant purchasers or funders relevant to the surgical and medical instrument industry, making it highly relevant.
This committee's regulation of the FDA (critical for medical device approval and post-market surveillance) and oversight of the NIH (research funding) directly impacts the surgical and medical instrument manufacturing sector, making it highly relevant.
This committee's oversight of intellectual property (patents for medical devices) and antitrust laws (potential mergers or market practices) makes it highly relevant for BLFS.
Funding decisions by this committee for the Department of Veterans Affairs directly impact government healthcare contractors and medical device manufacturers, making it highly relevant for BLFS as a surgical and medical instrument supplier.